Double-blind, placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer's disease. - Becker,R.E.; Colliver,J.A.; Markwell,S.J.; Moriearty,P.L.; Unni,L.K.; Vicari,S. (Alzheimer Dis Assoc Disord, 1996)